"And the company has not even started the US pilot study yet." is an over concern. OSL has made a head start already. ASX Announcement 31 January 2019 Quarterly Activities & Cash Flow Report Quarter ended 31 December 2018 OncoSil’s US OncoPaC-1 clinical study has now closed for recruitment with 9 patients successfully implanted.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)